Application 217498
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MOMETASONE FUROATE | MOMETASONE FUROATE | SPRAY, METERED;NASAL | 0.05MG/SPRAY | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217498-001 | MOMETASONE FUROATE | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | 2680178bc6a6… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217498-001 | MOMETASONE FUROATE | 0.05MG/SPRAY | SPRAY, METERED / NASAL | 2024-11-22 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MOMETASONE FUROATE | MOMETASONE FUROATE | Aurohealth LLC | 48ba8c52-73b6-4ee9-ba13-756a645a9183 | 2024-11-25 | Warnings | 217498 ANDA217498 |